Literature DB >> 2191085

Stereotaxic thalamotomy--experiences from the levodopa era.

K Wester1, E Hauglie-Hanssen.   

Abstract

After the introduction of levodopa drugs in the late 1960s, the number of thalamotomies fell dramatically world wide. However, as the Parkinsonian tremor proved rather resistant to levodopa treatment, the interest in this operation has been reviewed. During 1978-86, 51 stereotaxic thalamotomies were performed in 48 patient in our department. Thirty three of these patients had Parkinsonism, nine multiple sclerosis (MS) and the remaining six had various other involuntary movement disorders. The operation was most useful in the Parkinsonian group. Nearly 80% of these patients gained a substantial benefit in their daily lives. Patients with MS were all in advanced stages of the disease, and the operation was tried as a last resort. They had less benefit and more complications from operation than the other patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191085      PMCID: PMC488061          DOI: 10.1136/jnnp.53.5.427

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  The surgical treatment of parkinsonism.

Authors:  F J GILLINGHAM; W S WATSON; A A DONALDSON; J A NAUGHTON
Journal:  Br Med J       Date:  1960-11-12

2.  Neurosurgical alleviation of intention tremor of multiple sclerosis and cerebellar disease.

Authors:  I S COOPER
Journal:  N Engl J Med       Date:  1960-09-01       Impact factor: 91.245

3.  [Stereotaxic operations in the treatment of the tremors in multiple sclerosis].

Authors:  T Riechert; D Richter
Journal:  Schweiz Arch Neurol Neurochir Psychiatr       Date:  1972

4.  Functional neurosurgery in the treatment of multiple sclerosis.

Authors:  A Arsalo; A Hänninen; L Laitinen
Journal:  Ann Clin Res       Date:  1973-04

5.  A qualitative and quantitative evaluation of parkinsonians three to six years following thalamotomy.

Authors:  J M Van Buren; C L Li; D Y Shapiro; W G Henderson; D A Sadowsky
Journal:  Confin Neurol       Date:  1973

6.  Indications for surgical treatment of Parkinson's disease after levodopa therapy.

Authors:  J van Manen; J D Speelman; R J Tans
Journal:  Clin Neurol Neurosurg       Date:  1984       Impact factor: 1.876

7.  What happened to VIM thalamotomy for Parkinson's disease?

Authors:  R R Tasker; J Siqueira; P Hawrylyshyn; L W Organ
Journal:  Appl Neurophysiol       Date:  1983

8.  The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study.

Authors:  P J Kelly; F J Gillingham
Journal:  J Neurosurg       Date:  1980-09       Impact factor: 5.115

9.  Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral thalamotomy.

Authors:  K Matsumoto; F Shichijo; T Fukami
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

10.  Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease.

Authors:  P J Kelly; J E Ahlskog; S J Goerss; J R Daube; J R Duffy; B A Kall
Journal:  Mayo Clin Proc       Date:  1987-08       Impact factor: 7.616

View more
  4 in total

1.  Cognitive function in patients with Parkinson's disease undergoing stereotaxic thalamotomy.

Authors:  M Lund-Johansen; K Hugdahl; K Wester
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

2.  Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease.

Authors:  D Caparros-Lefebvre; S Blond; P Vermersch; N Pécheux; J D Guieu; H Petit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

3.  Surgical management of Parkinson's disease: update and review.

Authors:  Y Chao; L Gang; Z L Na; W Y Ming; W S Zhong; W S Mian
Journal:  Interv Neuroradiol       Date:  2008-02-01       Impact factor: 1.610

Review 4.  Tremor in multiple sclerosis.

Authors:  Marcus Koch; Jop Mostert; Dorothea Heersema; Jacques De Keyser
Journal:  J Neurol       Date:  2007-02-21       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.